We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+4.97%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$83.2B
AUM Growth
+$1.08B
Cap. Flow
-$819M
Cap. Flow %
-0.99%
Top 10 Hldgs %
34.54%
Holding
3,151
New
709
Increased
920
Reduced
837
Closed
626

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.06B
2
UNH icon
UnitedHealth
UNH
+$935M
3
UBER icon
Uber
UBER
+$426M
4
BA icon
Boeing
BA
+$312M
5
CRM icon
Salesforce
CRM
+$309M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Consumer Discretionary 14.92%
3 Healthcare 12.54%
4 Financials 8.46%
5 Industrials 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLAB icon
1876
Photronics
PLAB
$1.72B
$685K ﹤0.01%
+29,084
New +$712K
DC icon
1877
Dakota Gold
DC
$629M
$684K ﹤0.01%
310,916
+193,689
+165% +$437K
AIV
1878
Aimco
AIV
$375M
$684K ﹤0.01%
+75,200
New +$650K
RCKY icon
1879
Rocky Brands
RCKY
$322M
$682K ﹤0.01%
29,923
+7,115
+31% +$174K
TZOO icon
1880
Travelzoo
TZOO
$77.8M
$680K ﹤0.01%
+34,079
New +$587K
SKY icon
1881
Champion Homes
SKY
$4.58B
$677K ﹤0.01%
+7,682
New +$743K
VOYA icon
1882
Voya Financial
VOYA
$9.07B
$677K ﹤0.01%
+9,829
New +$768K
IYT icon
1883
PUT
iShares US Transportation ETF
IYT
$2.31B
$676K ﹤0.01%
+10,000
New +$707K
NVCT icon
1884
Nuvectis Pharma
NVCT
$625M
$674K ﹤0.01%
124,571
+81,757
+191% +$512K
DOUG icon
1885
Douglas Elliman
DOUG
$160M
$674K ﹤0.01%
+403,347
New +$776K
TXG icon
1886
10x Genomics
TXG
$5.97B
$673K ﹤0.01%
46,861
-420,262
-90% -$6.63M
CRVL icon
1887
CorVel
CRVL
$3.14B
$671K ﹤0.01%
+6,035
New +$676K
KYNB
1888
Kyntra Bio
KYNB
$28.2M
$671K ﹤0.01%
50,621
-7,173
-12% -$66.7K
ASPI icon
1889
ASP Isotopes
ASPI
$475M
$670K ﹤0.01%
147,997
-852,717
-85% -$4.54M
ESOA icon
1890
Energy Services of America
ESOA
$281M
$669K ﹤0.01%
53,042
-35,276
-40% -$461K
JHX icon
1891
James Hardie Industries
JHX
$15.6B
$669K ﹤0.01%
+21,714
New +$750K
RM icon
1892
Regional Management Corp
RM
$392M
$668K ﹤0.01%
19,654
+5,171
+36% +$162K
DNA icon
1893
Ginkgo Bioworks
DNA
$503M
$665K ﹤0.01%
+67,684
New +$580K
TMCI icon
1894
Treace Medical Concepts
TMCI
$260M
$661K ﹤0.01%
88,910
-337,820
-79% -$2.26M
UFI icon
1895
UNIFI
UFI
$121M
$657K ﹤0.01%
105,066
+1,092
+1% +$6.69K
CHCT
1896
Community Healthcare Trust
CHCT
$543M
$656K ﹤0.01%
34,170
-26,269
-43% -$476K
MEI icon
1897
Methode Electronics
MEI
$525M
$656K ﹤0.01%
55,641
-75,917
-58% -$826K
OPRX icon
1898
OptimizeRx
OPRX
$119M
$653K ﹤0.01%
+134,446
New +$751K
OBE
1899
Obsidian Energy
OBE
$628M
$652K ﹤0.01%
+112,569
New +$642K
MATW icon
1900
Matthews International
MATW
$900M
$650K ﹤0.01%
+23,465
New +$601K

Similar funds

Marshall Wace's Q4 2024 Portfolio in Review

As of Q4 2024, Marshall Wace held 3,151 positions worth $83.2B, up 1.3% from $82.1B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Marshall Wace's Q4 2024 filing shows 709 new, 920 increased, 837 reduced and 626 closed positions. Its largest new stake was Boeing: 1,988,038 shares worth $352M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.09B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q4 2024 buy was Boeing: 1,988,038 shares worth $352M.
  • Marshall Wace added most to Apple in Q4 2024, an estimated $1.06B increase.
  • Marshall Wace's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.09B.
  • Marshall Wace fully exited GE Vernova in Q4 2024, selling an estimated $439M.
  • Marshall Wace's ten largest holdings make up 35% of its $83.2B portfolio in Q4 2024.
  • Marshall Wace opened 709 new positions and closed 626 in Q4 2024.
  • Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $83.2B.

Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.